Rice Hall James & Associates, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rice Hall James & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$144.95 - $152.29 $26.2 Million - $27.6 Million	-180,920 Reduced 68.78%	82,110 $12.4 Million
Q2 2022 Aug 08, 2022	SELL	$83.14 - $145.99 $1.16 Million - $2.04 Million	-13,976 Reduced 5.05%	263,030 $38.3 Million
Q1 2022 May 05, 2022	SELL	$110.08 - $142.92 $544,345 - $706,739	-4,945 Reduced 1.75%	277,006 $32.8 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $179,414 - $267,115	-1,799 Reduced 0.63%	281,951 $38.9 Million
Q3 2021 Nov 09, 2021	SELL	$98.85 - $138.91 $702,922 - $987,789	-7,111 Reduced 2.44%	283,750 $39.4 Million
Q2 2021 Jul 29, 2021	BUY	$65.78 - $105.02 $1.73 Million - $2.76 Million	26,303 Added 9.94%	290,861 $28.2 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $17 Million - $24.3 Million	264,558 New	264,558 $18.1 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.